Use access key #2 to skip to page content.

IBDvalueinvestin (98.37)

2 stocks Post Great earnings but being Punished by Shorts



November 06, 2009 – Comments (1) | RELATED TICKERS: GSIH , PRX.DL2

that were expecting even bigger EPS , GSI posts .22 eps being pummeled from opening gap down to $4.27 after earlier hitting $4.59

Another is PRX which posted .76 eps and also is being pummeled from opening gap of $23.67 to current $22.62

1 Comments – Post Your Own

#1) On November 06, 2009 at 11:30 AM, IBDvalueinvestin (98.37) wrote:

PRX looking to get approvals on an additional $6.5B worth of drugs.

PRX Total revenue nearly doubled to $294.8 million

Analysts on average expected earnings of 49 cents a share on revenue of $290.4 million, according to Thomson Reuters I/B/E/S.

PRX said it currently has about 27 abbreviated new drug applications pending with the U.S. health regulators, 13 of which the company believes have first-to-file or first-to-market opportunities with a brand value of about $6.5 billion.

Report this comment

Featured Broker Partners